0001209191-23-018952.txt : 20230315
0001209191-23-018952.hdr.sgml : 20230315
20230315172008
ACCESSION NUMBER: 0001209191-23-018952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230314
FILED AS OF DATE: 20230315
DATE AS OF CHANGE: 20230315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kidron Miriam
CENTRAL INDEX KEY: 0001409232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35813
FILM NUMBER: 23736213
MAIL ADDRESS:
STREET 1: 2 ELZA STREET
CITY: JERUSALEM
STATE: L3
ZIP: 93706
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980376008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-844-1164
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-14
0
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP
0001409232
Kidron Miriam
2 ELZA STREET
JERUSALEM
L3
93706
ISRAEL
1
1
0
0
Chief Scientific Officer
Common Stock
2023-03-14
4
S
0
100000
2.01
D
201666
D
These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.
/s/ Miriam Kidron
2023-03-15